Huh et al.
JOCFeatured Article
following the conditions B. The structure of the major diaster-
eomer 23a was determined by X-ray crystallography after
recrystallization from MeOH/EtOAc: mp 171-172°; IR (neat)
3250, 1610 cm-1; HRMS calcd for C12H20NO2 [M þ Hþ]
a solid single diastereomer by following general conditions
A or 133 mg (56%) of 26a as a solid single product by follow-
ing general conditions B. The structure of the 26a was
determined by X-ray crystallography after recrystallization
from tetrahydrofuran: mp 154-155 °C; IR (thin layer) 3282
(br), 2916, 1606 cm-1; HRMS calcd for C14H24 NO2 [M þ Hþ]
238.1807, found 238.1792; 1H NMR (400 MHz, CDCl3) δ 0.92
(s, 3H), 1.08 (s, 3H), 1.32 (tdd, J = 14.0, 10.8, 3.2 Hz, 1H),
1.45-1.56 (m, 1H), 1.74-1.82 (m, 1H), 1.85-1.92 (m, 1H),
1.99-2.08 (m, 2H), 2.28 (ddd, J = 14.8, 12.0, 2.8 Hz, 1H),
2.38-2.44 (m, 1H), 2.57 (dd, J=6.0 Hz, 14,4 Hz, 1H), 3.23 (d,
J=11.2 Hz, 1H), 3.62 (dd, J=9.6, 4.0 Hz, 1H), 3.67 (d, J=11.2
Hz, 1H), 3.83 (t, J=4.4 Hz, 1H), 5.04-5.09 (m, 2H), 5.75-5.85
(m, 2H); 13C NMR (100 MHz, CDCl3) δ 19.9, 21.5, 24.4, 34.3,
36.7, 37.3, 38.0, 39.4, 56.4, 65.6, 79.5, 116.4, 136.5, 175.0.
(S*)-2-((S*)-3-(Benzyloxy)-1-hydroxypropyl)cyclohexanone
(anti-42) and (S*)-2-((R*)-3-(Benzyloxy)-1-hydroxypropyl)cy-
clohexanone (syn-42). The Evans protocol for titanium aldol
reaction was followed.24 To a solution of cyclohexanone (0.35
mL, 3.4 mmol) in CH2Cl2 (17 mL) was added TiCl4 (0.40 mL,
3.6 mmol) as a neat solution dropwise at -78 °C. Three minutes
later, i-Pr2EtN (0.68 mL, 3.9 mmol) was added to the resulting
pale yellow solution which resulted in a gradual color change to
dark red. The reaction mixture was then stirred at -78 °C for 1 h
to ensure the formation of the titanium enolate. A solution of 3-
benzyloxypropionaldehyde (41, 0.46 g, 2.8 mmol) in CH2Cl2
(2.8 mL) was then added slowly over 5 min. After the addition of
aldehyde, the reaction mixture was stirred at -78 °C for 2 h
before quenching with aqueous saturated NH4Cl solution
(20 mL). After being warmed to rt, the reaction mixture was
diluted with 50 mL of ether. The organic layer was separated and
washed successively with aqueous saturated NaHCO3 solution
(30 mL) and brine (30 mL) and then dried over Na2SO4, filtered,
and concentrated to afford crude mixture. NMR analysis on the
resulting crude mixture showed a diastereomeric ratio of 1.8:1.
The resulting crude mixture was purified by column chroma-
tography (SiO2, 33% EtOAc in hexanes) to afford 42 (316 mg,
46%) as an inseparable mixture of two diastereomers: IR (thin
layer) 3507, 2932, 2859, 1702, 1451, 1100 cm-1; HRMS calcd for
1
210.1494, found 210.1508. Major diastereomer 23a: H NMR
(400 MHz, CDCl3) δ 1.31-1.44 (m, 1H), 1.45-1.62 (m,
1H), 1.73-1.82 (m, 2H), 1.84-1.96 (m, 3H), 2.10 (dt, J=15.2,
8.0 Hz, 1H) 2.33-2.25 (m, 1H), 2.47-2.41 (m, 1H), 2.54 (ddd,
J=14.4, 6.8, 2.4 Hz, 1H), 3.41 (dd, J=9.6, 4.0 Hz, 1H) 3.51 (td,
J=11.2, 6.0 Hz, 1H), 3.94 (ddd, J=11.6, 8.0, 2.0 Hz, 1H), 4.53
(dd, J=dd, J=6.0, 4.0 Hz, 1H) 5.08-5.02 (m, 2H), 5.86-5.72
(m, 1H); 13C NMR (100 MHz, CDCl3) δ 21.2, 32.1, 33.6, 36.7,
37.3, 38.0, 45.3, 66.6, 72.7, 116.7, 136.4, 174.6. Minor diaster-
eomer 23b: 1H NMR (400 MHz, CDCl3, diagnostic peaks only
from the mixture) 3.69 (ddd, J =12.0, 9.2, 7.2 Hz, 1H), 4.41 (m,
1H) ppm.
2-(1-Azidohex-5-en-3-yl)cyclohex-2-enone (24). Isolated as a
side product from the reaction described above, following
conditions A: IR (neat) 2924, 2096, 1674, 1456 cm-1; HRMS
calcd for C12H18NO [M - N2 þ Hþ] 192.1383, found 192.1369.
1H NMR (400 MHz, CDCl3) δ 1.71-1.81 (m, 2H), 1.93-2.00
(m, 2H), 2.15-2.27 (m, 2H), 2.37-2.44 (m, 4H), 2.76 (apparent
quint, J=7.2 Hz, 1H) 3.17 (t, J=7.2 Hz, 2H), 4.93-4.95 (m, 1H),
4.97 (dd, J=1.2, 1.2 Hz, 1H), 5.58-5.69 (m, 1H) 6.69 (t, J=4.4
Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 22.8, 26.1, 32.4, 36.1,
38.6, 38.8, 49.7, 116.4, 136.4, 140.7, 145.7, 198.9.
(1S*,3S*,9R*,9aS*)-9-Allyl-3-hexyl-1-hydroxyhexahydro-
1H-pyrrolo[1,2-a]azepin-5(6H)-one (25a). Prepared from 2-cy-
clohexen-1-one (12, 0.10 mL, 0.10 mmol) and 3-azidononanal
(18, 290 mg, 1.6 mmol) using either general conditions A or
general conditions B. After purification with column chroma-
tography, 101 mg (34%) of 25a/b was obtained as a solid
mixture of two diastereomers (ratio=4.2:1) by following the
general conditions A or 173 mg (59%) of 25a/b as a solid mixture
of four diastereomers (ratio between major and sum of all other
minor diastereomer=1.8:1) by following the general conditions
B. The structure of the major diastereomer 25a was determined
by X-ray crystallography after recrystallization from MeOH/
EtOAc: mp 96-98 °C; IR (neat) 1614 cm-1; HRMS calcd for
C18H32NO2 [M þ Hþ] 294.2428, found 294.2426. Major dia-
stereomer 25a: 1H NMR (400 MHz, CDCl3) δ 0.88 (t, J=6.8 Hz,
3H), 1.25 (m, 9H), 1.49-1.58 (m, 2H), 1.66-1.72 (m, 2H), 1.76
(dt, J=13.2, 6.0 Hz, 1H), 1.88-1.97 (m, 2H), 2.00-2.12 (m, 2H),
2.31-2.50 (m, 3H), 3.40 (dd, J=8.8, 5.2 Hz, 1H) 4.13 (m, 1H),
4.42 (dd, J=10.8, 5.2 Hz, 1H), 5.02 (d, J=10.8 Hz, 1H), 5.05 (d,
J = 17.2 Hz, 1H), 5.72-5.81 (m, 1H); 13C NMR (100 MHz,
CDCl3) δ 14.1, 18.3, 22.6, 25.7, 28.1, 29.2, 31.9, 33.6, 34.0, 34.8,
36.3, 37.0, 55.8, 65.5, 71.3, 116.7, 136.5, 173.3. Minor diaster-
eomer 25b: 1H NMR (400 MHz, CDCl3) 0.86 (t, J=6.8 Hz, 3H),
1.33 (m, 9 H), 1.37-1.57 (m, 3H), 1.79-1.97 (m, 5H), 2.03-2.11
(m, 1H), 2.34-2.46 (m, 3H), 3.35 (dd, J=9.6, 4.4 Hz), 4.20 (m,
1H), 4.43 (dd, J = 10.8, 6.4 Hz, 1H), 5.04-5.11 (m, 2H),
5.76-5.83 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 14.0, 21.8,
22.6, 26.3, 29.3, 31.8, 34.3, 34.5, 36.9, 37.1, 37.5, 41.9, 56.2, 70.3,
74.6, 116.9, 136.4, 173.8.
1
C16H22NaO3 [M þ Hþ] 285.1461, found 285.1440; H NMR
(400 MHz, CDCl3) δ 1.36-1.86 (m, 7H), 1.95-2.02 (m, 1H),
2.04-2.11 (m, 1H), 2.18-2.38 (m, 3H), 2.94 (d, J=3.6 Hz, 0.3H,
syn-42), 3.49 (d, J=4.0 Hz, 0.7H, anti-42), 3.57-3.60 (m, 0.6H,
syn-42), 3.62 (t, J=6.4 Hz, 1.4H, anti-42), 3.91 (dddd, J=9.2,
6.8, 4.0, 2.8 Hz, 0.7H, anti-42), 4.19 (dddd, J=9.2, 3.6, 3.6, 3.6
Hz, 0.3H, syn-42), 4.44 (s, 0.6H, syn-42), 4.45 (s, 1.4H, anti-42),
7.19-7.29 (m, 5H) ppm.
Acknowledgment. We thank the National Institutes of
Health (GM-49093) for support of this work. We also thank
Dr. David Vander Valde and Sarah Ann Neuenswander for
NMR analysis and Dr. Victor Day for X-ray crystallogra-
phy.
Supporting Information Available: Experimental details and
characterization data for substrates 10 and 11 and their syn-
thetic intermediates, 1H/13C NMR spectra for new compounds,
and X-ray data for compounds 19 (major), 23a, 25a, and 26a
(CIF). This material is available free of charge via the Internet at
(1S*,9R*,9aS*)-9-Allyl-1-hydroxy-2,2-dimethylhexahydro-
1H-pyrrolo[1,2-a]azepin-5(6H)-one (26a). Prepared from 2-cy-
clohexen-1-one (2, 0.10 mL, 0.10 mmol) and 3-azido-2,2-
dimethylpropanal (22, 290 mg, 1.6 mmol) using either general
conditions A or general conditions B. After purification with
column chromatography, 100 mg (42%) of 26a was obtained as
7626 J. Org. Chem. Vol. 74, No. 20, 2009